RxDoctor Payments Data

Christopher Udovich, MD

Family Medicine · Mokena, ILNPI 1548335326

Payments from drug & device makers

$339in general payments, 2019–2025

Across 15 payments — averaging $22.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Baxter Healthcare$74
  • Johnson & Johnson$53
  • Merck$44
  • Dexcom, Inc.$43
  • Abbott$23
  • Ironshore Pharmaceuticals Inc.$23
  • plus $78 from 5 others

What the payments were for

  • Food & beverage$26578%
  • Other$7422%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$339 in reported general payments places this provider in the 55th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$229,622
Medicare patients
519
Services billed
3,391

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate83$102,833
EliquisApixaban83$90,254
JardianceEmpagliflozin28$45,642
FarxigaDapagliflozin Propanediol24$31,781
TrulicityDulaglutide18$17,028
BrilintaTicagrelor13$11,879
Breo ElliptaFluticasone/Vilanterol18$9,812
NamzaricMemantine Hcl/Donepezil Hcl12$7,576
Atorvastatin Calcium571$6,164
NovologInsulin Aspart20$5,807
SymbicortBudesonide/Formoterol Fumarate14$5,006
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$4,982
Advair HfaFluticasone Propion/Salmeterol11$4,955
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog14$4,713
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate21$4,399

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$44$102,83383 claims
PfizerEliquis$13$90,25483 claims
AbbVieNamzaric, Synthroid$18$8,74441 claims
Novo NordiskNovolog$15$5,80720 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Mokena

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →